New Balance Between Scientific & Commercial Practicalities for Diverse Clinical Trials
Despite regulatory ambiguity, most sponsors remain committed to diversity in clinical trials as a scientific and operational imperative.
Already a DIA Member? Sign in. Not a member? Join.
Sign in
Not a Member?
Virtual training course explains FDA regulations and expectations for content, submission, and review of INDs and NDAs.